Guidance for States, Plans, and Issuers on State External Review Processes\r\nRegarding Requirements in the No Surprises Act
Guidance for states, plans, and issuers regarding implementation of Section 110 of Title I (the No Surprises Act (NSA)) of Division BB of the Consolidated Appropriations Act (CAA), 2021, and implementing regulations as part of an interim final rule with comment period, entitled “Requirements Related to Surprise Billing; Part II,” and the expanded scope of adverse benefit determinations eligible for external review.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 30, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.